SCT630
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SCT630, covering 2021-01-29 to 2021-01-29. Get the full timeline:
Most recent: Clinical Trial Update: The Purpose of This Research Study is to Compare the Efficacy and Safety of SCT630 and Adalimumab (HUMIRA®) in Adults With Plaque Psoriasis [Phase 3]